Stock Analiz

Opus Genetics, Inc. (IRD) stock forecast and price target

Price $3.98 · data as of November 13, 2026

12-month price target

Average target$13.94
Upside / downside+250.3%
Analysts17
ConsensusStrong buy
Low $8.00Average $13.94High $20.00

Gold marker: average target · white marker: today’s price ($3.98)

Analyst ratings

Strong buy 3Buy 14Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.29−61.9%$13M
Next fiscal year
ends December 31, 2027
$-0.76+41.0%$12M
Quarter after
ends December 31, 2026
$-0.09+57.1%$1M

Consensus of the analysts covering Opus Genetics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Opus Genetics stock price target?

The average 12-month target from 17 analysts is $13.94, 250.3% above the current price of $3.98 Targets range from $8.00 to $20.00.

Is Opus Genetics a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 14 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Opus Genetics expected to earn?

Analysts expect EPS of $-1.29 for the fiscal year ending December 31, 2026 and $-0.76 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.